Loading
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. - H Shares Stock: price and insider trades · Hong Kong
No insider purchase over the last 90 days. The latest, by GE Junyou, was filed 28 May 2026.
Insider Decl.
46
Thresholds
n/a
Buy Volume
n/a
1 ops. · all time
Sell Volume
€137M
40 ops. · all time
Who traded when
BuySaleLIU Gexin30 sales
GE Junyou1 buy5 sales
FENG Hao4 sales
Lai Degui1 sale
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 18,074 of 26,280 companies
39.0
score / 100
Value33
Quality45
FCF yld-0.3%
Earn yld-0.3%
EV/EBITDA·
ROE2.9%
Gross mgn72%
Net mgn-19%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
HK$472.80
Analyst consensus
19 analysts1.20/5
HK$520.00Target HK$619.67(+31%)HK$765.30
Income statement
RevenueHK$2.1B
Gross profitHK$1.5B72% margin
EBITDA-HK$249.2M-12% margin
Net income-HK$382M7.2% margin
Valuation
PER (trailing)656.7x
PER (forward)135.7x
P/Book17.6x
Beta0.04
Balance sheet & cash
Market capHK$113B
Total debtHK$88.4M
Free Cash Flow-HK$306.6M
Debt / Equity2%
Profitability & ownership
ROE2.9%
ROA-0.0%
% insiders59.4%
% institutions27.3%
Last declaration on 23 October 2026
Declarations46 total
118,200 shares@ HK$457.54ShareXHKGHKEX:DA20261023E00347
71,400 shares@ HK$452.85ShareXHKGHKEX:DA20261022E00498
64,100 shares@ HK$475.60ShareXHKGHKEX:DA20261022E00499
66,400 shares@ HK$465.77ShareXHKGHKEX:DA20261022E00500
44,600 shares@ HK$441.620.019% mcap2.2% of flowShareXHKGHKEX:DA20261015E00430
78,000 shares@ HK$458.580.034% mcap3.9% of flowShareXHKGHKEX:DA20261016E00447
69,100 shares@ HK$437.890.029% mcap3.3% of flowShareXHKGHKEX:DA20261015E00431
31,800 shares@ HK$445.490.013% mcap1.6% of flowShareXHKGHKEX:DA20261015E00432
36,000 shares@ HK$451.620.015% mcap1.8% of flowShareXHKGHKEX:DA20261015E00433
66,000 shares@ HK$439.940.027% mcap3.7% of flowShareXHKGHKEX:DA20261009E00404
52,600 shares@ HK$456.050.023% mcap3.0% of flowShareXHKGHKEX:DA20261009E00403
52,242 shares@ HK$442.9946.1% of flowShareXHKGHKEX:DA20260702E00579
102,817 shares@ HK$442.9946.1% of flowShareXHKGHKEX:DA20260702E00570
42,754 shares@ HK$434.3318.8% of flowShareXHKGHKEX:DA20260702E00569
86,200 shares@ HK$434.335.0% of flowShareXHKGHKEX:DA20260702E00562
207,300 shares@ HK$442.9912.2% of flowShareXHKGHKEX:DA20260702E00563
21,723 shares@ HK$434.3318.8% of flowShareXHKGHKEX:DA20260702E00578
52,242 shares@ HK$442.9946.1% of flowShareXHKGHKEX:DA20260702E00584
21,723 shares@ HK$434.3318.8% of flowShareXHKGHKEX:DA20260702E00583
42,100 shares@ HK$399.022.2% of flowShareXHKGHKEX:DA20260625E00346
86,800 shares@ HK$425.374.9% of flowShareXHKGHKEX:DA20260625E00348
4,813 shares@ HK$421.654.1% of flowShareXHKGHKEX:DA20260626E00264
41,200 shares@ HK$414.552.3% of flowShareXHKGHKEX:DA20260625E00345
26,839 shares@ HK$419.1922.5% of flowShareXHKGHKEX:DA20260626E00262
52,822 shares@ HK$419.1922.5% of flowShareXHKGHKEX:DA20260626E00257
25 of 46 declarations
About Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. - H Shares
Sichuan Kelun-Biotech Biopharmaceutical, a healthcare company listed in Hong Kong (market capitalisation HKD 113.0 billion, 59.4% of the capital held by insiders), appears in our data only since May 28, 2026: 37 filings up to October 16, 2026, from 4 filers.
It is a selling record. Among open-market trades there are 36 sales worth EUR 120.1 million, with a median of EUR 3,194,824, against a single purchase with no amount, so 3% purchases. Director LIU Gexin accounts for 26 filings, all sales; the three largest are EUR 10.3 million on June 29, 2026, EUR 8.7 million on June 1, 2026 and EUR 7.6 million on June 2, 2026.
Read moreShow less
Among the other directors, GE Junyou has 6 filings (1 purchase, 5 sales) and FENG Hao 4 sales. The record contains no grant or option exercise. All 37 filings fall within the last twelve months. They are published a median of 2 days after the trade.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
